Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy

Documenti analoghi

• Tumour‐infiltrating lymphocytes, tertiary lymphoid structures and myxoid stroma predict upstaging of ductal carcinoma in situ in breast biopsies
  di: Chung‐Yen Huang, et al.
  Pubblicazione: (2025)
• Making sense of TILs : recommendations for morphological assessment of tumour‐infiltrating lymphocytes in gastro‐oesophageal carcinoma
  di: Ylva A Weeda, et al.
  Pubblicazione: (2026)
• Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy
  di: Chung‐Yen Huang, et al.
  Pubblicazione: (2024)
• Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
  di: Raul S Gonzalez, et al.
  Pubblicazione: (2024)
• Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast
  di: Clarissa Jing Wen Wong, et al.
  Pubblicazione: (2024)